Bioaffinity Technologies (BIAF) Stock
Small medical diagnostics company in early development. Here's the price, business snapshot, and what's worth knowing about Bioaffinity Technologies in September 2026.
bioAffinity Technologies Inc (BIAF) is a very small-cap company operating in the medical diagnostics space. With a market capitalisation of around $12.73m, it is typically classed as an early-stage, speculative investment: revenues may be limited, operations can depend on research and development, regulatory approvals and partnerships, and the stock can be thinly traded. Key catalysts for value can include clinical data releases, regulatory decisions or licensing deals, while main risks include funding needs, development setbacks and market liquidity. Because of its size and stage, the share price can be highly volatile and subject to dilution if new capital is raised. This summary is for general educational purposes only and not personal financial advice — investors should read the company’s filings, check recent financial reports and consider seeking regulated advice as investments can fall as well as rise.
About This Stock
BIOAFFINITY TECHNOLOGIES INC
BIAF
Current Price
$6.30
Potential 12 Month Profit
N/A
Sector
N/A
Industry
N/A
Ticker
BIAF
Market Cap
$9.25M
Potential 12 Month Profit
N/A
Sector
N/A
Industry
N/A
Sixth Month Growth Performance
Stock Performance Snapshot
Financial Health
BIOAFFINITY TECHNOLOGIES INC is generating solid revenue and cash flow with a good profit margin.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Early-stage catalysts
Clinical data, regulatory decisions and partnership news can materially move the share price, though outcomes are uncertain and volatility can be high.
R&D and funding
Progress in diagnostics development could unlock value but typically requires ongoing funding; capital raises can dilute existing shareholders.
Liquidity and size
A small market capitalisation and thin trading can amplify price swings and make buying or selling large positions harder—consider diversification.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.